| Report ID | 283145 |
| Drug Identification Number | 02241093 |
| Brand name | TEMODAL |
| Common or Proper name | temozolomide capsules |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TEMOZOLOMIDE |
| Strength(s) | 5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 5CAP |
| Anatomical Therapeutical Chemical (ATC) code | L01AX |
| Anatomical Therapeutical Chemical (ATC) description | ALKYLATINGAGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-05-11 |
| Actual start date | |
| Estimated end date | 2026-05-29 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-17 | French | Compare |
| v1 | 2026-04-17 | English | Compare |
Showing 1 to 2 of 2